Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Lushang Freda PharmaceuticalLtd Temettü
Temettü kriter kontrolleri 3/6
Lushang Freda PharmaceuticalLtd is a dividend paying company with a current yield of 1.29% that is well covered by earnings.
Anahtar bilgiler
1.3%
Temettü verimi
62%
Ödeme oranı
| Sektör ortalama getirisi | 2.4% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | CN¥0.100 |
| Hisse başına kazanç | CN¥0.24 |
| Temettü verim tahmini | 2.1% |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Doing What It Can To Lift Shares
Jun 21
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)
Feb 27Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 600223 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Büyüyen Temettü: 600223's dividend payments have increased, but the company has only paid a dividend for 5 years.
Piyasaya Karşı Temettü Getirisi
| Lushang Freda PharmaceuticalLtd Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (600223) | 1.3% |
| Pazarın Alt %25'i (CN) | 0.6% |
| Pazarın En İyi %25'i (CN) | 2.2% |
| Sektör Ortalaması (Real Estate) | 2.4% |
| Analist tahmini (600223) (3 yıla kadar) | 2.1% |
Önemli Temettü: 600223's dividend (1.29%) is higher than the bottom 25% of dividend payers in the CN market (0.58%).
Yüksek Temettü: 600223's dividend (1.29%) is low compared to the top 25% of dividend payers in the CN market (2.21%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonable payout ratio (62.4%), 600223's dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its reasonably low cash payout ratio (41.9%), 600223's dividend payments are well covered by cash flows.